Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: August 2017

Rutgers Cancer Institute and National Cancer Institute Scientists’ DNA Repair Research Bolstered with $4 Million in Multi-Source Support

New Brunswick, NJ, August 23, 2017 — Cancer researchers have learned that by sharing their knowledge and forming strategic partnerships, they can more rapidly advance their discoveries leading to drug development, clinical trials and ultimately new therapies for cancer patients.

Thanks to $4 million in combined support, including $2 million in funding from the Robert Wood Johnson Foundation, physician-scientists at Rutgers Cancer Institute of New Jersey are embarking on a new collaboration with the National Cancer Institute’s (NCI) intramural Center for Cancer Research (CCR). NCI is part of the National Institutes of Health. Continue reading

Op-Ed: NJ Assn. of State Colleges and Universities’ Dr. Michael Klein Urges ‘Modernize Contracts Laws for NJ’s State Colleges, Universities’

Dr. Michael Klein

Trenton, NJ, August 23, 2017NJ Spotlight on August 14 published the following op-ed by Michael W. Klein, J.D., Ph.D., executive director of the New Jersey Association of State Colleges and Universities:

The ideal college, according to President James Garfield, was having Mark Hopkins, the president of Williams College from 1836 to 1872, “on one end of a log and a student on the other.”

Times have changed a bit since Garfield graduated from Williams in 1856. To be sure, professors and their classrooms are important, but so too are libraries, laboratories, computers, and high-speed connections to the Internet.  Continue reading

Trump Signs FDA User Fee Agreement into Law; PhRMA and BIO Applaud the Move

Washington, DC, August 21, 2017 — President Donald J. Trump on Friday signed into law a funding package for the Food and Drug Administration (FDA) that also takes steps to lower drug prices.

The FDA Reauthorization Act (FDARA) of 2017 reauthorizes a program in which drug and medical device makers pay the FDA a fee for every new product application.  The agency uses those funds to hire more people and speed up approvals.

The user fee program must be reauthorized every five years. The current program expires at the end of September, and if it hadn’t been signed into law before then, the agency would have had to lay off workers. Continue reading

Trump Administration Unveils First Blueprint for Federal Investment in Science and Tech; Departs from Its Budget Request

President Donald Trump

Washington, DC, August 21, 2017 — Jeffrey Mervis reports in Science that President Donald J. Trump on August 17 translated his campaign promise to “make America great again” into his administration’s first blueprint for federal investment in science and technology.

The White House on issued a four-page memo telling federal agencies that their research dollars should be focused on delivering short-term dividends in strengthening national defense and border security, the economy, and “energy dominance,” as well as improving public health. Continue reading

NJIT Researcher Throws a Global Ham Radio ‘Party’ to Study August 21 Solar Eclipse

Newark, NJ, August 20, 2017 — When a solar eclipse plunges the United States into darkness August 21, New Jersey Institute of Technology’s (NJIT) Nathaniel Frissell, Ph.D., will be stationed directly along the shadow’s path, leading one of the largest ionospheric experiments in the history of space science from the back porch of a cabin in Gilbertsville, Kentucky.

With a 102-foot wire antenna, he will contact a network of ham radio operators he’s assembled around the world to test the strength and reach of their high frequency signals as one measure of the eclipse’s impact on Earth’s atmosphere.

More than a week in advance, nearly 200 operators — from New Jersey, to Tennessee, to Wyoming in the U.S. and at far-flung locales such as Chile, Greece and India — are already signed on to be “citizen-scientists” that day by recording their contacts with one another. Their number grows daily. Continue reading

NJ Lawmakers Establish Legislative Manufacturing Caucus to Fund Expansion of Technical and Vocational Schools

Trenton, NJ, August 19, 2017 — Vince Calio reports in NJBIZ that vocational and technical workers in the state are set to get a large boost from the government.

State lawmakers on August 15 created the Legislative Manufacturing Caucus, which will work over the next year to create legislation that would issue municipal bonds to fund the creation and expansion of technical vocation schools in the state.

Those schools are generally designed to train workers without four-year college degrees for careers in manufacturing, and give them a path to a four-year degree. Continue reading

NJEDA to Make Additional Lab Space Available for State’s Growing Biotechnology Companies

Trenton, NJ, August 18, 2017 — The New Jersey Economic Development Authority (EDA) yesterday announced it will again expand its successful incubator program with the creation of the Biotechnology Development Center (BDC) on the 50-acre Technology Centre of New Jersey research park in North Brunswick.

The BDC will offer suites of intermediate lab and office space from 3,400 to 10,000 square feet for emerging life sciences companies including those that have outgrown incubator space and other early stage companies looking to expand. More than 32,600 square feet of new space is now available at the BDC. Continue reading

Rutgers Cancer Institute Reports Favorable Safety Profile Seen in Immunotherapy Drug in Aggressive Form of Lung Cancer

Dr. Janice M. Mehnert

New Brunswick, NJ, August 18, 2017 — The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and “promising durable clinical activity” in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease.

That is according to data from a phase 1b clinical trial conducted by Rutgers Cancer Institute of New Jersey investigators and colleagues at centers around the world. The work appears in the current online edition of the Journal of Clinical Oncology (doi: 10.1200/JCO.2017.72.5069).

Janice M. Mehnert, MD, director of the Phase 1/Investigational Therapeutics Program at Rutgers Cancer Institute, and senior director on the work said, “Immunotherapy drugs put the body’s natural defenses bak to work by targeting the PD-L1 protein and PD-1 receptor and blocking their ability to prevent T cells from destroying cancer cells.” Continue reading

Stockton University Brain Research Team Seeking Volunteers in Atlantic City Area

Galloway, NJ, August 18, 2017 — Stockton University is seeking volunteers for a research project being conducted in Atlantic City, which will explore which lifestyle factors have the most significant impact on the degree of connectivity among different regions of the brain.

“As we age, we routinely participate in screenings of blood pressure, cholesterol and blood sugar,” noted Jessica Fleck, associate professor of Psychology.  “However, many individuals have never participated in a screening of brain health and function.” Continue reading

Christie Administration Announces $500,000 Grant Opportunity to Integrate Health Care for Military, Veterans and First Responders

Trenton, NJ, August 17, 2017 — The New Jersey Department of Health yesterday announced a $500,000 grant opportunity to support a pilot program to integrate primary care, behavioral health, palliative care, hospice and telehealth services for military persons, veterans and first responders.

This one-year grant opportunity is available to New Jersey hospitals, healthcare systems, federally qualified health centers, or state university providers of behavioral health services.

Military personnel, veterans and first responders often deal with primary care and behavioral health challenges. Offering the integration of healthcare across the continuum will help create a seamless system of care. Continue reading